L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

NCT01105130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Male Erectile Disorder
Prostate Cancer
Radiation Toxicity

Interventions

OTHER: Placebo
DRUG: Oral L-Arginine
DRUG: Oral L-Arginine

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]